Equity Analysis

Quarterly Results

    Cipla Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500087
    INE059A01026
    320.5750473
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    CIPLA
    33.91
    111517.58
    EPS(TTM)
    Face Value()
    Div & Yield %:
    40.73
    2
    0.62
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales3798.313736.463857.73
Other Operating Income583.02497.98460.46
Other Income 265.36319.24157.98
Total Income4646.694553.684476.17
Total Expenditure 3025.473009.063113.50
PBIDT1621.221544.621362.67
Interest 9.066.610.31
PBDT1612.161538.011362.36
Depreciation135.02179.81135.95
Tax348.69329.81340.34
Fringe Benefit Tax0.000.000.00
Deferred Tax14.31-1.30-8.95
Reported Profit After Tax1114.141029.69895.02
Extra-ordinary Items 96.38114.150.00
Adjusted Profit After Extra-ordinary item1017.76915.54895.02
EPS (Unit Curr.)14.9914.1711.09
EPS (Adj) (Unit Curr.)14.9914.1711.09
Calculated EPS (Unit Curr.)13.8012.7511.09
Calculated EPS (Adj) (Unit Curr.)13.8012.7511.09
Calculated EPS (Ann.) (Unit Curr.)55.2051.0244.35
Calculated EPS (Adj) (Ann.) (Unit Curr.)55.2051.0244.35
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity161.47161.47161.45
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)42.6841.3435.32
PBDTM(%)42.4441.1635.32
PATM(%)29.3327.5623.20
Dividend Per Share(Rs)0.000.000.00
Diluted EPS14.9814.1611.09